Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World Studies.

Andrea LucianiAntonio GhidiniLorenzo DottoriniFausto Petrelli

Published in: Drugs & aging (2021)

Our findings suggest that ICIs could be safely administered in older individuals with comparable survival outcomes with respect to younger individuals. Future studies should include some form of geriatric assessment to improve patient stratification.

Keyphrases

community dwelling
case control
middle aged
physical activity
randomized controlled trial
systematic review
case report
hip fracture